M
Monimoi Therapeutics develops transformative cancer therapies by integrating chemical proteomics and covalent-based molecular technologies. The company focuses on creating durable treatments by targeting high-value, hard-to-drug cancer-promoting proteins. This approach utilizes deep human translational insights to overcome resistance mechanisms in existing cancer treatments.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Monimoi Therapeutics develops transformative cancer therapies by integrating chemical proteomics and covalent-based molecular technologies. The company focuses on creating durable treatments by targeting high-value, hard-to-drug cancer-promoting proteins. This approach utilizes deep human translational insights to overcome resistance mechanisms in existing cancer treatments.